Cargando…
Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC-TT cell line
Medullary thyroid cancer (MTC) is an aggressive neuroendocrine tumor (NET). Previous research has shown that activation of Notch signaling has a tumor suppressor role in NETs. The potential therapeutic effect of thiocoraline on the activation of the Notch pathway in an MTC cell line (TT) was investi...
Autores principales: | Tesfazghi, Sara, Eide, Jacob, Dammalapati, Ajitha, Korlesky, Colin, Wyche, Thomas P, Bugni, Tim S, Chen, Herbert, Jaskula-Sztul, Renata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Science Inc
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3892805/ https://www.ncbi.nlm.nih.gov/pubmed/24403239 http://dx.doi.org/10.1002/cam4.118 |
Ejemplares similares
-
Thiocoraline activates the Notch pathway in carcinoids and reduces tumor progression in vivo
por: Wyche, Thomas P., et al.
Publicado: (2014) -
Histone deacetylase inhibitor thailandepsin-A activates Notch signaling and suppresses neuroendocrine cancer cell growth in vivo
por: Jang, Samuel, et al.
Publicado: (2017) -
Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1
por: Jang, Samuel, et al.
Publicado: (2017) -
Chrysin suppresses the achaete-scute complex-like1 and alters the neuroendocrine phenotype of carcinoids
por: Somnay, Yash R., et al.
Publicado: (2015) -
2018 Synaptic vesicle 2 receptors as a novel targets for
neuroendocrine cancer therapy
por: Jaskula-Sztul, Renata, et al.
Publicado: (2018)